软骨发育不全-话题@MedSci

#软骨发育不全#

1篇内容 | 1530人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2255968, encodeId=dcc42255968ee, content=<a href='/topic/show?id=4c14935467e' target=_blank style='color:#2F92EE;'>#软骨发育不全#</a>, objectTitle=婴儿和幼儿软骨发育不全患者的管理, objectType=article, longId=867107, objectId=f0bb86e10781, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241211/1733879532275_8538692.jpg, objectUrl=/article/show_article.do?id=f0bb86e10781, replyNumber=0, likeNumber=20, createdTime=2025-03-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=f0bb86e10781, moduleTitle=婴儿和幼儿软骨发育不全患者的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0bb86e10781)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2244454, encodeId=2fb32244454d6, content=<a href='/topic/show?id=4c14935467e' target=_blank style='color:#2F92EE;'>#软骨发育不全#</a> <a href='/topic/show?id=216f12269ee1' target=_blank style='color:#2F92EE;'>#Vosoritide#</a>, objectTitle=Genet Med：Vosoritide对软骨发育不全儿童健康相关生活质量（HRQoL）的影响, objectType=article, longId=856516, objectId=a3b38565168d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719541633437_8538692.png, objectUrl=/article/show_article.do?id=a3b38565168d, replyNumber=0, likeNumber=32, createdTime=2024-12-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=a3b38565168d, moduleTitle=Genet Med：Vosoritide对软骨发育不全儿童健康相关生活质量（HRQoL）的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3b38565168d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239344, encodeId=1a8822393442e, content=<a href='/topic/show?id=4c14935467e' target=_blank style='color:#2F92EE;'>#软骨发育不全#</a>, objectTitle=韩国年轻软骨发育不全患者的生长模式及神经外科手术预测性, objectType=article, longId=852840, objectId=d6498528401d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716169587115_92910.png, objectUrl=/article/show_article.do?id=d6498528401d, replyNumber=0, likeNumber=34, createdTime=2024-11-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=d6498528401d, moduleTitle=韩国年轻软骨发育不全患者的生长模式及神经外科手术预测性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6498528401d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2238181, encodeId=7651223818105, content=<a href='/topic/show?id=4c14935467e' target=_blank style='color:#2F92EE;'>#软骨发育不全#</a> <a href='/topic/show?id=96c3984438' target=_blank style='color:#2F92EE;'>#Infigratinib#</a>, objectTitle=NEJM：口服Infigratinib治疗软骨发育不全儿童的疗效与安全性研究, objectType=article, longId=851914, objectId=bcb985191467, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719494105549_2570354.jpg, objectUrl=/article/show_article.do?id=bcb985191467, replyNumber=0, likeNumber=0, createdTime=2024-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=bcb985191467, moduleTitle=NEJM：口服Infigratinib治疗软骨发育不全儿童的疗效与安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcb985191467)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184032, encodeId=66f1218403203, content=<a href='/topic/show?id=4c14935467e' target=_blank style='color:#2F92EE;'>#软骨发育不全#</a>, objectTitle=Lancet Child Adolesc Health：Vosoritide在5岁以下儿童和婴儿中治疗软骨发育不全的安全性和有效性评估, objectType=article, longId=810991, objectId=f596810991eb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021918358_4754896.jpeg, objectUrl=/article/show_article.do?id=f596810991eb, replyNumber=0, likeNumber=94, createdTime=2024-01-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f596810991eb, moduleTitle=Lancet Child Adolesc Health：Vosoritide在5岁以下儿童和婴儿中治疗软骨发育不全的安全性和有效性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f596810991eb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=915268, encodeId=72a39152686f, content=<a href='/topic/show?id=4c14935467e' target=_blank style='color:#2F92EE;'>#软骨发育不全#</a>是<a href='/topic/show?id=5a8be955621' target=_blank style='color:#2F92EE;'>#罕见病#</a>，<a href='/topic/show?id=9088e904482' target=_blank style='color:#2F92EE;'>#维昇药业#</a>, objectTitle=维昇药业TransCon C-型利钠肽II期中国临床试验申请获批, objectType=article, longId=205596, objectId=d82020559619, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021110/1610261752373_5295905.jpg, objectUrl=/article/show_article.do?id=d82020559619, replyNumber=0, likeNumber=190, createdTime=2021-01-10, rootId=0, userName=lifefamily, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d82020559619, moduleTitle=维昇药业TransCon C-型利钠肽II期中国临床试验申请获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d82020559619)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

软骨发育不全

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#软骨发育不全#

婴儿和幼儿软骨发育不全患者的管理

2025-03-13发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#软骨发育不全# #Vosoritide#

Genet Med：Vosoritide对软骨发育不全儿童健康相关生活质量（HRQoL）的影响

2024-12-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#软骨发育不全#

韩国年轻软骨发育不全患者的生长模式及神经外科手术预测性

2024-11-26发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#软骨发育不全# #Infigratinib#

NEJM：口服Infigratinib治疗软骨发育不全儿童的疗效与安全性研究

2024-11-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#软骨发育不全#

Lancet Child Adolesc Health：Vosoritide在5岁以下儿童和婴儿中治疗软骨发育不全的安全性和有效性评估

2024-01-26发表于上海

lifefamily (审核中...)

前往app查看评论内容

#软骨发育不全#是#罕见病#，#维昇药业#

维昇药业TransCon C-型利钠肽II期中国临床试验申请获批

2021-01-10

科室
- - 订阅+
  - 更多科室
工具
服务